Skip to content
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

Day: 22 July 2022

  1. Home
  2. Archives: July 2022

Autologous Cord Blood Infusions Are Safe and
Feasible in Young Children with Autism Spectrum
Disorder: Results of a Single-Center Phase I
Open-Label Trial

autism stem cells

Despite advances in early diagnosis and behavioral therapies, more effective treatments for children with autism spectrum disorder (ASD) are needed

Continue reading
biobank Cord blood cord blood stem cells mesenchymal stem cells Stem cells Swiss stem cells biotech

Recent Posts

  • Progress in clinical trials of stem cell therapy for cerebral palsy
  • Stem cells: are we ready for therapy?
  • Stemedica announces clinical trial for IV stem cell treatment for chronic ischemic stroke
  • Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage
  • Kamsiyochukwu Cured of Sickle Cell by Cord Blood Transplant

Recent Comments

No comments to show.
Linkedin
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us
  • Home
  • Identity
  • Our Services
  • Countries presence
  • News
  • Contact Us

©2022 Swiss Stem Cells Biotech SA – P.IVA CH277426754